PT2575787T - Formulações farmacêuticas de estatinas e ácidos gordos ómega-3 para o encapsulamento - Google Patents

Formulações farmacêuticas de estatinas e ácidos gordos ómega-3 para o encapsulamento

Info

Publication number
PT2575787T
PT2575787T PT117890145T PT11789014T PT2575787T PT 2575787 T PT2575787 T PT 2575787T PT 117890145 T PT117890145 T PT 117890145T PT 11789014 T PT11789014 T PT 11789014T PT 2575787 T PT2575787 T PT 2575787T
Authority
PT
Portugal
Prior art keywords
statins
omega
encapsulation
fatty acids
pharmaceutical formulations
Prior art date
Application number
PT117890145T
Other languages
English (en)
Original Assignee
Accucaps Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accucaps Industries Ltd filed Critical Accucaps Industries Ltd
Publication of PT2575787T publication Critical patent/PT2575787T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT117890145T 2010-06-03 2011-06-03 Formulações farmacêuticas de estatinas e ácidos gordos ómega-3 para o encapsulamento PT2575787T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2706270A CA2706270C (en) 2010-06-03 2010-06-03 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation

Publications (1)

Publication Number Publication Date
PT2575787T true PT2575787T (pt) 2020-07-28

Family

ID=45066009

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117890145T PT2575787T (pt) 2010-06-03 2011-06-03 Formulações farmacêuticas de estatinas e ácidos gordos ómega-3 para o encapsulamento

Country Status (12)

Country Link
US (2) US11975108B2 (pt)
EP (3) EP4445959A3 (pt)
JP (2) JP5972261B2 (pt)
AU (1) AU2011261117B2 (pt)
CA (1) CA2706270C (pt)
DK (1) DK2575787T3 (pt)
ES (1) ES2807498T3 (pt)
HU (1) HUE050830T2 (pt)
MX (2) MX369477B (pt)
PL (1) PL2575787T3 (pt)
PT (1) PT2575787T (pt)
WO (1) WO2011150505A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014095628A1 (en) * 2012-12-17 2014-06-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
EP3738586A1 (en) 2013-10-30 2020-11-18 Patheon Softgels Inc. Enteric soft capsules comprising polyunsaturated fatty acids
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
CA2939990C (en) 2014-02-28 2018-07-10 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
WO2015185240A1 (en) 2014-06-04 2015-12-10 Sigma-Tau Industrire Farmaceutiche Riunite S.P.A. Compositions containing simvastatin in omega-3 polyunsaturated fatty acids
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
WO2015200563A1 (en) * 2014-06-26 2015-12-30 Banner Life Sciences Llc Enhanced bioavailability of polysaturated fatty acids
WO2016024844A1 (ko) * 2014-08-13 2016-02-18 한국유나이티드제약 주식회사 오메가-3 지방산 에스테르 및 스타틴계 약물을 포함하는 경구용 복합제제
KR101950907B1 (ko) * 2016-02-05 2019-02-21 한국유나이티드제약 주식회사 지용성 약물 및 방유성 기제가 코팅된 고형제제를 포함하는 경구용 복합제제
WO2017171484A1 (ko) * 2016-03-31 2017-10-05 한미약품 주식회사 오메가-3 지방산 또는 이의 에스테르, 및 하이드록시메틸글루타릴 코엔자임에이 환원효소 억제제를 포함하는 경구용 복합 제제
US11547693B2 (en) 2019-07-29 2023-01-10 Matthias Rath Ascorbate in the prevention of statin induced vascular calcification
US10736872B1 (en) * 2019-09-05 2020-08-11 Matthias W. Rath Pharmaceutical mixture to treat statin induced vascular calcification
WO2021142062A1 (en) 2020-01-10 2021-07-15 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
EP4185277A4 (en) * 2020-07-23 2024-08-07 Procaps SA Soft shell gelatin capsules
BR102021011153B1 (pt) 2021-06-09 2022-12-27 Fernando Campos Barbosa Composição fitoterápica associada a suplementos polivitamínicos e minerais
KR20240029726A (ko) * 2021-07-23 2024-03-06 프로캡스 에스에이 연질 쉘 젤라틴 캡슐

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1803440A (en) * 1929-07-25 1931-05-05 Newspaper Mechanical Sales Com Coin control for vending machines
US2775080A (en) 1950-05-26 1956-12-25 American Cyanamid Co Method of forming powder-and-liquid filled capsules
US2711814A (en) * 1953-08-14 1955-06-28 Bartlett And Company Grain Apparatus for cleaning flat bottom grain tanks
US3536074A (en) 1968-03-29 1970-10-27 Alfred Aufhauser Oral administration of a pill,tablet or capsule
US4655027A (en) 1980-11-24 1987-04-07 Chasman Sydney A Method and apparatus for forming capsules
BR9407261A (pt) 1993-06-18 1996-09-24 Smithkline Beecham Corp Particulas encapsuladas em cápsulas flexíveis de gelatina
ATE451926T1 (de) * 1997-07-31 2010-01-15 Abbott Respiratory Llc Zusammensetzung enthaltend einen hmg-coa- reduktasehemmer und eine nikotinsäureverbindung zur behandlung von hyperlipidämie
US6238616B1 (en) 1998-12-14 2001-05-29 Timecaps Inc. Method of manufacturing gelatin capsule containing powder or time release pellets
US6574945B2 (en) 2001-03-21 2003-06-10 Lumitek Llc Method for manufacturing a projectile containing chemiluminescent compounds
DE60219307T2 (de) * 2001-06-12 2008-01-10 Galephar M/F Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat
WO2004000731A2 (en) 2002-06-25 2003-12-31 Akzo Nobel N.V. Use of cationic layered materials, compositions comprising these materials, and the preparation of cationic layered materials
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040146537A1 (en) * 2003-01-28 2004-07-29 Ramachandran Radhakrishnan Oily wax matrix suspension formulation comprising pharmacologically active agents
CA2475765A1 (en) 2003-07-29 2005-01-29 L. Perrigo Company Tablet encapsulating machine
US20070276027A1 (en) * 2003-09-17 2007-11-29 Warner-Lambert Company Llc Crystalline Forms of [R-(R* ,R*)]-2-(4-Fluorophenyl)-Beta, -Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
CN1993121A (zh) * 2004-08-06 2007-07-04 变换药品公司 新的他汀药物组合物及相关治疗方法
ES2255426B1 (es) * 2004-10-19 2007-08-16 Gp Pharm, S.A. Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
US20070191467A1 (en) * 2004-12-06 2007-08-16 Reliant Pharmaceutical, Inc. Statin and omega-3 fatty acids for lipid therapy
CA2600429A1 (en) * 2005-03-08 2006-09-14 Reliant Pharmaceuticals, Inc. Treatment with statin and omega-3 fatty acids and a combination product thereof
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
US7652068B2 (en) * 2005-12-20 2010-01-26 Cenestra Llc Omega 3 fatty acid formulations
US8784886B2 (en) 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
EP2081550B2 (en) * 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
US20070218141A1 (en) * 2006-03-15 2007-09-20 Ashis Kumar Mehta Simvastatin compositions
EP2046305A2 (en) * 2006-06-26 2009-04-15 Valpharma S.A. Pharmaceutical composition for the oral administration of omega polyenoic fatty acids
US8481084B2 (en) * 2007-05-23 2013-07-09 Amcol International Corporation Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
ITMI20072142A1 (it) * 2007-11-08 2009-05-09 Yervant Zarmanian Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3
WO2009087938A1 (ja) * 2008-01-10 2009-07-16 Takeda Pharmaceutical Company Limited カプセル製剤
US20110082119A1 (en) * 2008-06-13 2011-04-07 Takashi Yano Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
GB0818472D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
CA3065589C (en) * 2010-06-03 2022-04-26 Catalent Ontario Limited Multi phase soft gel capsules, apparatus and method thereof

Also Published As

Publication number Publication date
EP4445959A3 (en) 2025-01-08
PL2575787T3 (pl) 2020-11-02
ES2807498T3 (es) 2021-02-23
EP3581173A1 (en) 2019-12-18
EP3581173C0 (en) 2024-08-28
EP3581173B1 (en) 2024-08-28
CA2706270A1 (en) 2011-12-03
US11975108B2 (en) 2024-05-07
EP2575787A1 (en) 2013-04-10
HUE050830T2 (hu) 2021-01-28
EP2575787B1 (en) 2020-05-27
EP4445959A2 (en) 2024-10-16
EP2575787A4 (en) 2013-11-27
US20230233472A1 (en) 2023-07-27
MX2019013095A (es) 2020-01-30
MX369477B (es) 2019-11-08
AU2011261117B2 (en) 2015-08-13
JP2013527205A (ja) 2013-06-27
WO2011150505A1 (en) 2011-12-08
JP5972261B2 (ja) 2016-08-17
AU2011261117A1 (en) 2012-12-13
CA2706270C (en) 2020-01-07
US20130115281A1 (en) 2013-05-09
DK2575787T3 (da) 2020-08-03
JP2016138143A (ja) 2016-08-04
MX2012013933A (es) 2013-02-11

Similar Documents

Publication Publication Date Title
PL2575787T3 (pl) Formulacje farmaceutyczne statyn i kwasów tłuszczowych omega-3 do kapsułkowania
ZA201202263B (en) Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
EP2846779A4 (en) STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS
IL228516A (en) A compound for oral administration containing an omega-3 fatty acid ester and rosovastatin
EP2498602A4 (en) STABILIZED FORMULATIONS FROM FATTY ACIDS
IL234104A (en) METHOD FOR PREPARING Medium-length fatty acids with triglycerides
IL234814A (en) Omega 3 fatty acid ester preparations
EP2827868B8 (en) Pharmaceutical compositions comprising fatty acid esters
SI3159329T1 (sl) Uporaba 2-hidroksi derivatov polinenasičenih maščobnih kislin kot zdravila
ZA201302760B (en) Novel omega-3 and omega-6 fatty acid compositions and uses thereof
EP2785852A4 (en) COMPOSITIONS COMPRISING FATTY ACIDS CONTAINING CARBON ATOMS AND METHODS OF PREPARATION AND USE THEREOF
EP2706847A4 (en) COUPLERS FOR MEDIUM CHAIN FATTY ACIDS AND DISINFECTANT COMPOSITIONS
ZA201400336B (en) Fatty acid composition and plant extract and pharmaceutical preparation and application thereof
EP2560633B8 (en) Intravenous omega-3 fatty acid compositions & method of use
PT2525789T (pt) Formulações farmacêuticas de naproxeno para encapsulação de gel mole e combinações das mesmas
IL213354A (en) Alpha-monoclonal fatty acid alpha history for use as a drug
GB201304550D0 (en) Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof
PL2525827T3 (pl) Farmaceutyczne formulacje loratadyny do enkapsulacji i ich kombinacje
EP2845585A4 (en) COMPOSITION OF FATTY ACID ESTERS OF TRHEHALOSIS
AU2010903057A0 (en) Acetylenation of fatty acids
PL391825A1 (pl) Sposób otrzymywania estrów i laktonów
ZA201105275B (en) Pharmaceutical formulation containing atorvastatin and method for the preparation thereof